DarioHealth Reports Third Quarter 2025 Financial and Operating Results
— Third quarter 2025 revenue was $5.0 million, compared to $7.4 million in the third quarter of 2024, and $5.4 million in the second quarter of 2025 — Targeting $12.4 million in new business, reflecting both committed annual recurring revenue (“CARR”) and late-stage opportunities nearing completion; 2026 pipeline expanded to $69 million — Exceeded 2025 […]